pubmed-article:8780818 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8780818 | lifeskim:mentions | umls-concept:C0043474 | lld:lifeskim |
pubmed-article:8780818 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:8780818 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:8780818 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:8780818 | lifeskim:mentions | umls-concept:C0132326 | lld:lifeskim |
pubmed-article:8780818 | lifeskim:mentions | umls-concept:C1413246 | lld:lifeskim |
pubmed-article:8780818 | lifeskim:mentions | umls-concept:C1826471 | lld:lifeskim |
pubmed-article:8780818 | lifeskim:mentions | umls-concept:C1837441 | lld:lifeskim |
pubmed-article:8780818 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
pubmed-article:8780818 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:8780818 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:8780818 | pubmed:dateCreated | 1996-12-5 | lld:pubmed |
pubmed-article:8780818 | pubmed:abstractText | Nevirapine is a non-nucleoside reverse transcriptase inhibitor of HIV-1 which exhibits synergy in vitro with zidovudine (ZDV) and also is active against ZDV-resistant HIV. We evaluated the activity and safety of nevirapine in combination with ZDV in patients receiving long-term ZDV therapy. | lld:pubmed |
pubmed-article:8780818 | pubmed:language | eng | lld:pubmed |
pubmed-article:8780818 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8780818 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8780818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8780818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8780818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8780818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8780818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8780818 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8780818 | pubmed:month | Jun | lld:pubmed |
pubmed-article:8780818 | pubmed:issn | 0269-9370 | lld:pubmed |
pubmed-article:8780818 | pubmed:author | pubmed-author:CarpCC | lld:pubmed |
pubmed-article:8780818 | pubmed:author | pubmed-author:SoriceFF | lld:pubmed |
pubmed-article:8780818 | pubmed:author | pubmed-author:CooperD ADA | lld:pubmed |
pubmed-article:8780818 | pubmed:author | pubmed-author:BoucherC ACA | lld:pubmed |
pubmed-article:8780818 | pubmed:author | pubmed-author:VelleWW | lld:pubmed |
pubmed-article:8780818 | pubmed:author | pubmed-author:ImrieAA | lld:pubmed |
pubmed-article:8780818 | pubmed:author | pubmed-author:de JongM DMD | lld:pubmed |
pubmed-article:8780818 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8780818 | pubmed:volume | 10 | lld:pubmed |
pubmed-article:8780818 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8780818 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8780818 | pubmed:pagination | 635-41 | lld:pubmed |
pubmed-article:8780818 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:meshHeading | pubmed-meshheading:8780818-... | lld:pubmed |
pubmed-article:8780818 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8780818 | pubmed:articleTitle | A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group. | lld:pubmed |
pubmed-article:8780818 | pubmed:affiliation | HIV Medicine Unit, St. Vincent's Hospital, Sydney, Australia. | lld:pubmed |
pubmed-article:8780818 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8780818 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:8780818 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:8780818 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:8780818 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780818 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780818 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780818 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780818 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780818 | lld:pubmed |